MEF2C TRANSCRIPTION FACTOR IS ASSOCIATED WITH THE GENETIC AND EPIGENETIC RISK ARCHITECTURE OF SCHIZOPHRENIA AND IMPROVES COGNITION IN MICE

Large scale consortia mapping the genomic risk architectures of schizophrenia provide vast amounts of molecular information, with largely unexplored therapeutic potential. We harnessed publically available information from the Psychiatric Genomics Consortium, and report MYOCYTE ENHANCER FACTOR 2C (M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Psychiatry
Autori principali: Mitchell, Amanda C., Javidfar, Behnam, Pothula, Venu, Ibi, Daisuke, Shen, Erica Y., Peter, Cyril J., Bicks, Lucy, Fehr, Tristan, Jiang, Yan, Brennand, Kristen J., Neve, Rachael L., Gonzalez-Maeso, Javier, Akbarian, Schahram
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5966823/
https://ncbi.nlm.nih.gov/pubmed/28115742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2016.254
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi